Share on LinkedInShare on LinkedIn

ARTICLE · 01 MARCH 2019

No PTAB Do Over: After SAS Remand, PTAB Denies All Grounds

Jones Day
Jones Day
Contributor
Jones Day

Jones Day

Jones Day is a global law firm with more than 2,400 lawyers in 40 offices across five continents....

View firm profile
Explore more from Jones Day

In three petitions filed in 2014, BioDelivery asserted 17 unpatentability grounds against a patent owned by MonoSol.

United StatesIntellectual Property

Last April, in SAS Institute, Inc. v. Iancu, 138 S. Ct. 1348 (2018), the Supreme Court held that after instituting an inter partes review, the PTAB must decide the patentability of all of the claims the petitioner has challenged. Subsequently, in PGS Geophysical AS v. Iancu, 891 F.3d 1354 (Fed. Cir. 2018), the Federal Circuit made clear that the reasoning and conclusion of SAS also applies to all asserted unpatentability grounds. SAS ended the PTAB's prior practice of instituting inter partes reviews on only a subset of challenged claims or a subset of unpatentability grounds. The impact of SAS has since reverberated through the PTAB and related court proceedings, even in inter partes reviews instituted years ago.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from